dostarlimab,nivolumab,ipilimumab
gsk,bms
#wcgic2022 #crcsm
provocative question from dr thierry andre - what is the soc now in #dmmr larc? the n=14 dostarlimab mskcc data will not be sufficient for funding in many jurisdictions incl we need more data - multi centre phase 2s and #rwe do we need 6m of io? 
Cancer Doctor, Professor, Lifelong Learner  #GIcancer ???? @UBC @BCCancer @CCTG #Prez @CAMO #TEDxSpeaker #MedTwitter Tweets are my own